Volume 8, Number 3—March 2002
Synopsis
Human Campylobacteriosis in Developing Countries1
Akitoye O. Coker*
, Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†
, Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†
Table 4
Trends in Resistance to Ciprofloxacin by Campylobacter jejuni in selected developed countries up to year 2000
| Country | Period | Resistance strains (%) | Ref. | |
|---|---|---|---|---|
| Initial | Year 2000 | |||
| Freiburg, Germany | 1992-2000 | 22 | 32 | 41 |
| Styria, Austria | 1996-2000 | 25.2 | 40.2 | 42 |
| England and Wales, UK | 1993-2000 | 10 | 14.8 | 44 |
| Philadelphia, USA | 1995-2000 | <10 | 36 | 45 |
| Oslo, Norway | 1988-2000 | 6.1 | 36 | 46 |
1 Portions of this review were presented at the World Health Organization Consultation on the Increasing Incidence of Campylobacteriosis in Humans, Copenhagen, Denmark, November 1-25, 2000. In addition, relevant emerging information from the 11th International Workshop on Campylobacter, Helicobacter and Related Organisms, held in Freiburg, Germany, September 1-5, 2001, are included.
Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.